| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874183 | The Annals of Thoracic Surgery | 2013 | 8 Pages |
Abstract
Rapamycin effectively reduces recruitment of fibrocytes into tracheal allografts and mitigates development of tracheal luminal fibrosis. Further studies are needed to determine the cellular and molecular mechanisms that mediate the protective effect of rapamycin against BO.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jacob R. MD, Yunge MD, PhD, David A. BS, Damien J. MD, Matthew L. MD, Lucas G. MD, Irving L. MD, Christine L. MD, MBA,